Louis Boon Selected Research

Atherosclerotic Plaque (Atheroma)

3/2016	Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
6/2015	Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α.
1/2013	Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis Boon Research Topics

Disease

70	Neoplasms (Cancer) 05/2024 - 07/2007
51	Inflammation (Inflammations) 01/2024 - 10/2006
33	Infections 01/2024 - 03/2002
12	Asthma (Bronchial Asthma) 11/2020 - 10/2006
10	Hypersensitivity (Allergy) 01/2023 - 01/2005
10	Atherosclerosis 11/2022 - 02/2010
8	Arthritis (Polyarthritis) 01/2024 - 08/2007
8	Pneumonia (Pneumonitis) 10/2022 - 01/2016
7	Melanoma (Melanoma, Malignant) 12/2023 - 04/2015
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2008
6	Human Influenza (Influenza) 01/2021 - 08/2009
6	Glioma (Gliomas) 01/2021 - 07/2007
6	Eosinophilia 10/2018 - 10/2006
5	Obesity 02/2024 - 02/2007
5	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 02/2014
5	Rheumatoid Arthritis 01/2023 - 08/2006
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2017 - 08/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 10/2009
4	Neuroblastoma 01/2020 - 03/2014
4	Colitis 01/2020 - 07/2004
4	Insulin Resistance 01/2017 - 02/2007
4	Edema (Dropsy) 01/2017 - 07/2004
3	Mesothelioma 05/2024 - 07/2015
3	Peanut Hypersensitivity (Peanut Allergy) 01/2019 - 01/2005
3	Multiple Sclerosis 12/2017 - 08/2002
3	Atherosclerotic Plaque (Atheroma) 03/2016 - 01/2013
3	Thrombosis (Thrombus) 03/2016 - 11/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 07/2014
2	Herpes Simplex 03/2024 - 01/2017
2	Virus Diseases (Viral Diseases) 12/2023 - 01/2017
2	Necrosis 11/2022 - 02/2007
2	Carcinoma (Carcinomatosis) 10/2022 - 05/2014

Drug/Important Bio-Agent (IBA)

38	CytokinesIBA 01/2024 - 10/2006
23	AntigensIBA 01/2024 - 01/2005
21	AntibodiesIBA 01/2023 - 03/2004
13	Immune Checkpoint InhibitorsIBA 11/2023 - 07/2015
13	LigandsIBA 01/2022 - 05/2007
12	VaccinesIBA 01/2024 - 10/2009
11	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2005
10	Immunoglobulin G (IgG)IBA 01/2023 - 11/2005
9	AllergensIBA 01/2022 - 01/2005
9	CD40 Ligand (CD40L)IBA 03/2016 - 03/2004
8	Interleukin-10 (Interleukin 10)IBA 10/2022 - 09/2008
8	InterferonsIBA 04/2022 - 02/2007
8	Peptides (Polypeptides)IBA 01/2022 - 04/2009
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2006
7	Immunoglobulin E (IgE)IBA 01/2023 - 06/2007
7	Interleukin-17 (Interleukin 17)IBA 11/2022 - 03/2009
7	Interleukin-6 (Interleukin 6)IBA 10/2022 - 08/2011
7	AutoantigensIBA 01/2022 - 11/2002
6	RNA (Ribonucleic Acid)IBA 05/2024 - 10/2009
6	Interleukin-33IBA 01/2023 - 04/2015
6	Monoclonal AntibodiesIBA 01/2022 - 08/2002
5	Transcription Factors (Transcription Factor)IBA 12/2023 - 03/2009
5	Therapeutic UsesIBA 11/2023 - 02/2010
5	Immunoglobulin A (IgA)IBA 01/2023 - 08/2013
5	Interleukin-4 (Interleukin 4)IBA 10/2022 - 09/2008
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2021 - 04/2014
5	chenodeoxycholate sulfate conjugate (CDCS)IBA 11/2020 - 10/2011
5	OligosaccharidesIBA 01/2019 - 04/2010
5	OvalbuminIBA 10/2018 - 11/2009
5	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2010
5	Polysaccharides (Glycans)IBA 02/2016 - 03/2002
4	CollagenIBA 01/2024 - 06/2015
4	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2023 - 02/2016
4	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 12/2007
4	IntegrinsIBA 01/2018 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 06/2014
3	Granzymes (Granzyme)IBA 03/2024 - 01/2016
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2018
3	Interleukin-23 (Interleukin 23)IBA 11/2022 - 05/2009
3	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2013
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2020 - 07/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2020 - 05/2014
3	GlucocorticoidsIBA 01/2020 - 04/2014
3	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2016
3	Vorinostat FDA Link 01/2020 - 06/2016
3	InterleukinsIBA 07/2017 - 02/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2013
3	Insulin (Novolin)FDA Link 01/2017 - 02/2007
3	Interleukin-12 (IL 12)IBA 01/2016 - 10/2006
3	Interleukin-2 (IL2)IBA 03/2015 - 02/2012
2	Interferon Type IIBA 01/2024 - 05/2011
2	Immune Checkpoint ProteinsIBA 01/2024 - 11/2017
2	Poly I-CIBA 12/2023 - 01/2019
2	Blocking AntibodiesIBA 11/2023 - 11/2017
2	Sialic AcidsIBA 11/2023 - 01/2018
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2022 - 01/2018
2	Abatacept (Orencia)FDA Link 10/2022 - 06/2017
2	Interleukin-5 (Interleukin 5)IBA 10/2022 - 01/2016
2	src-Family KinasesIBA 06/2022 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 06/2022 - 01/2022
2	Proto-Oncogene Proteins c-hckIBA 06/2022 - 01/2020
2	InflammasomesIBA 01/2022 - 01/2021

Therapy/Procedure

40	Therapeutics 05/2024 - 05/2009
34	Immunotherapy 03/2024 - 07/2007
5	Drug Therapy (Chemotherapy) 10/2022 - 02/2015
4	Oncolytic Virotherapy 03/2024 - 01/2017